Datum Källa Rubrik Typ Alternativ
2024-06-17 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: Equity raise to accelerate growth Pressreleaser Visa Stäng
2024-06-13 Integrum Integrum AB: Integrum har genomfört en riktad nyemission om 961 539 B-aktier och tillförs cirka 50 miljoner kronor Pressreleaser Ladda ner | Visa Stäng
2024-06-13 Integrum Integrum AB: Integrum has carried out a directed new issue of 961,539 series B shares, raising proceeds of approximately SEK 50 million Pressreleaser Ladda ner | Visa Stäng
2024-06-13 Integrum Integrum AB: Integrum intends to carry out a directed new issue of series B shares of approximately SEK 50 million Pressreleaser Ladda ner | Visa Stäng
2024-06-13 Integrum Integrum AB: Integrum avser att genomföra en riktad nyemission av B-aktier om cirka 50 miljoner kronor Pressreleaser Ladda ner | Visa Stäng
2024-06-13 Integrum Integrum AB: Integrum signs Memorandum of Understanding with Coapt for the use of its pattern recognition technology with the e-OPRA[TM] Implant System Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 13 Jun 2024 | Integrum

Integrum AB: Integrum signs Memorandum of Understanding with Coapt for the use of its pattern recognition technology with the e-OPRA[TM] Implant System

Coapt is the leading developer of advanced control solutions for prosthetics. Their primary product is a pattern recognition intent decoder system, called Complete Control, designed to enhance the functionality and user experience of upper-limb prostheses, allowing seamless and personalized movements. The pattern recognition system uses machine learning algorithms, a form of artificial intelligence, or AI, to interpret electrical signals from the residual muscles of the amputee, which are then translated into movement. Complete Control continuously analyzes these signals, known as electromyographic signals, or EMG, to determine the intended movements of the user, allowing for more natural and intuitive control of the prosthetic limb.

Integrum is developing the e-OPRA[TM] Implant System, the world’s first upper-limb prosthetic control system using wired tissue-embedded electrodes. e-OPRA[TM] uses an implanted electrode system that both record and stimulate nerves and muscle tissues. By connecting this system with Coapt’s pattern recognition technology, Integrum aims to further improve the functionality of e-OPRA[TM].

”Coapt systems have been a complementary technology to prostheses users with Integrum’s OPRA[®] Implant System for some time now. This agreement further strengthens the working collaboration between our two companies and will result in the best possible solutions and future with e-OPRA[TM ]and Coapt.” Says Blair Lock, CEO of Coapt.

”By complementing the current control system of the e-OPRA[TM] with Coapt’s world leading pattern recognition system, we aim to refine the movement control of our implant system further and improve prothesis control. Together with Coapt, I am convinced we will deliver the best possible options for arm amputees, outperforming today’s technology. It might sound like science fiction, but it is happening now!” says Rickard Brånemark, CEO of Integrum.

2024-06-11 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: Commercial collaboration with Hanger Pressreleaser Visa Stäng
2024-06-11 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: xxx Pressreleaser Visa Stäng
2024-06-10 Integrum Integrum AB: Integrum enters collaboration and distribution agreement with Hanger - the leading provider of amputee care and prosthetics in the US Pressreleaser Ladda ner | Visa Stäng
2024-06-03 Redeye Redeye: Integrum - Getting ready for the marathon Pressreleaser Ladda ner | Visa Stäng
2024-06-03 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: On a profitable growth journey – Q4 review Pressreleaser Visa Stäng
2024-05-30 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: Slightly lower sales than expected – Q4 initial Pressreleaser Visa Stäng
2024-05-30 Integrum Integrum AB: Ett år med rekordomsättning Rapporter Ladda ner | Visa Stäng
2024-05-30 Integrum Integrum AB: A Record Year in Sales Rapporter Ladda ner | Visa Stäng
2024-05-29 Integrum Integrum AB: Integrum receives market approval for OPRA[® in Israel] Pressreleaser Ladda ner | Visa Stäng
2024-05-24 Integrum Integrum AB: Invitation to the Fourth Quarter 2023/24 Results Presentation Pressreleaser Ladda ner | Visa Stäng
2024-05-23 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: We expect positive momentum to continue – Q4 preview Pressreleaser Visa Stäng
2024-05-15 Integrum Integrum AB: Integrum has been granted a registered trademark for OPRA® Implant System in the EU Pressreleaser Ladda ner | Visa Stäng
2024-05-03 Integrum Integrum AB: Integrum launches short video documentary to showcase the company's efforts to treat combat amputees in Ukraine Pressreleaser Ladda ner | Visa Stäng
2024-05-02 Integrum Integrum AB: Integrum expands its product offering to the United Kingdom market Pressreleaser Ladda ner | Visa Stäng
2024-04-26 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: CBPR operations suspended Pressreleaser Visa Stäng
2024-04-25 Integrum Integrum AB: Integrum kommenterar nedstängningen av Center for Bionics and Pain Research Pressreleaser Ladda ner | Visa Stäng
2024-04-11 Carnegie Commissioned Research Carnegie Commissioned Research: Integrum: Anchoring its position as niche leader Pressreleaser Visa Stäng
2024-03-26 Integrum Integrum AB: Integrum expands its product offering into the Israeli market Pressreleaser Ladda ner | Visa Stäng
2024-03-19 Integrum Integrum AB: Health economic study shows positive outcome using Integrum's OPRA[TM] Implant System over socket prostheses in transfemoral amputees Pressreleaser Ladda ner | Visa Stäng
2024-03-18 Integrum Integrum AB: Integrums valberedning utsedd inför årsstämman 2024 Pressreleaser Ladda ner | Visa Stäng
2024-03-01 Redeye Redeye: Integrum Q3 - In line and no estimate changes Pressreleaser Ladda ner | Visa Stäng
2024-02-29 Integrum Integrum AB: CORRECTION A new record revenue quarter with 61% growth Rapporter Ladda ner | Visa Stäng
2024-02-29 Integrum Integrum AB: Rättelse Ett nytt kvartal med rekordintäkter och 61 % tillväxt Rapporter Ladda ner | Visa Stäng
2024-02-29 Integrum Integrum AB: Ett nytt kvartal med rekordintäkter och 61 % tillväxt Rapporter Ladda ner | Visa Stäng
2024-02-29 Integrum Integrum AB: A new record revenue quarter with 61% growth Rapporter Ladda ner | Visa Stäng
2024-02-23 Integrum Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation Pressreleaser Ladda ner | Visa Stäng
2024-01-31 Integrum Integrum AB: Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine Pressreleaser Ladda ner | Visa Stäng
2023-12-20 Integrum Integrum AB: Integrum establishes Center of Excellence in Ukraine Pressreleaser Ladda ner | Visa Stäng
2023-12-15 Integrum Integrum AB: Integrum's MDR certification is completed for the OPRA[TM] Implant System Pressreleaser Ladda ner | Visa Stäng
2023-12-05 Redeye Redeye: Integrum Q2 - Alive and kicking Pressreleaser Ladda ner | Visa Stäng
2023-12-04 Integrum Integrum AB: Record sales and profitability Rapporter Ladda ner | Visa Stäng
2023-12-04 Integrum Integrum AB: Rekordförsäljning och lönsamhet Rapporter Ladda ner | Visa Stäng
2023-11-30 Integrum Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-11-28 Integrum Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation Pressreleaser Ladda ner | Visa Stäng
2023-11-13 Integrum Integrum AB: Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data Pressreleaser Ladda ner | Visa Stäng
2023-11-10 Integrum Integrum AB: Correction missing MAR reference: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 Rapporter Ladda ner | Visa Stäng
2023-11-10 Integrum Integrum AB: Clinical study of Integrum's OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense Pressreleaser Ladda ner | Visa Stäng
2023-11-09 Integrum Integrum AB: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 Rapporter Ladda ner | Visa Stäng
2023-10-30 Integrum Integrum AB: Integrum's OPRA™ Implant System gets FDA approval for clinical study on below-knee amputations Pressreleaser Ladda ner | Visa Stäng
2023-10-27 Integrum Integrum AB: Integrum moves into Turkey Pressreleaser Ladda ner | Visa Stäng
2023-10-12 Integrum Integrum AB: Integrum announces the world's first long-term integrated bionic hand enriched with motor and sensory AI Pressreleaser Ladda ner | Visa Stäng
2023-10-10 Integrum Integrum AB: Integrum receives a Unitary Patent for Neuromotus in the EU Pressreleaser Ladda ner | Visa Stäng
2023-10-10 Integrum Integrum AB: Integrum welcomes Scott Flora as full board member Pressreleaser Ladda ner | Visa Stäng
2023-09-27 Integrum Årsstämmokommuniké - Integrum AB Pressreleaser Ladda ner | Visa Stäng
2023-09-27 Integrum Integrum AB: Integrum attends international expert workshop on osseointegration and bionic limb reconstruction Pressreleaser Ladda ner | Visa Stäng
2023-09-19 Integrum Integrum AB: Integrum participates in war-related amputee care workshop to support amputee care in Ukraine Pressreleaser Ladda ner | Visa Stäng
2023-09-14 Integrum Integrum AB: Integrum initiates a strategic review process to accelerate growth Pressreleaser Ladda ner | Visa Stäng
2023-09-11 Integrum Integrum AB: Integrum announces organizational changes and appoints Alex Winber as VP Sales and Marketing in the US Pressreleaser Ladda ner | Visa Stäng
2023-09-08 Integrum Integrum AB: Integrum receives reimbursement code for Axor II™ Pressreleaser Ladda ner | Visa Stäng
2023-09-06 Integrum Integrum AB: Integrum publicerar årsredovisning 2022/23 Pressreleaser Ladda ner | Visa Stäng
2023-08-31 Redeye Redeye: Integrum Q1 - Good start to fiscal year 2023e Pressreleaser Ladda ner | Visa Stäng
2023-08-31 Integrum Integrum AB: Integrum rapporterar högsta kvartalsintäkterna någonsin Rapporter Ladda ner | Visa Stäng
2023-08-31 Integrum Integrum AB: Integrum reports highest quarterly sales revenue ever Rapporter Ladda ner | Visa Stäng
2023-08-29 Integrum Kallelse till årsstämma i Integrum AB Pressreleaser Ladda ner | Visa Stäng
2023-07-13 Integrum Integrum AB: Integrum's technology using AI gives an above-elbow amputee unprecedented control of every finger in a bionic hand Pressreleaser Visa Stäng
2023-06-22 Integrum Integrum AB: Integrum har informerats om att Nämnden för prövning av oredlighet i forskning har friat Rickard Brånemark Pressreleaser Visa Stäng

Kommande händelser

3 Mar 2025 | Kvartalsrapport 2025-Q3
3 Jun 2025 | Bokslutskommuniké 2025